Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Vicore Pharma Holding AB

Closing information (x1000 EUR)

Closing information 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 43 More Arrow 251 Less Arrow 1
Earnings before taxes -25,952 Less Arrow -29,015 More Arrow -14,676
EBITDA -25,823 Less Arrow -28,476
Total assets 30,374 More Arrow 44,116 Less Arrow 40,500
Current assets 24,244 More Arrow 36,955 Less Arrow 32,662
Current liabilities 4,160 More Arrow 6,412 Less Arrow 4,413
Equity capital 25,977 More Arrow 37,481 Less Arrow 35,319
- share capital 3,677 Less Arrow 3,508 Less Arrow 2,499
Employees (average) 21 Less Arrow 16 Less Arrow 13

Financial ratios

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Solvency 85.5% Less Arrow 85.0% More Arrow 87.2%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -85.3% More Arrow -65.2% More Arrow -36.2%
Current ratio 582.8% Less Arrow 576.3% More Arrow 740.1%
Return on equity (ROE) -99.9% More Arrow -77.4% More Arrow -41.6%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 5 Less Arrow 3 More Arrow 5
Chg. No. of employees % 31% Less Arrow 23% More Arrow 63%

Total value of public sale

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.